1354910-15-8

Basic information

• Product Name: 4-{2-[4-(2,3-difluoro-benzyloxy)-phenyl]-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl}-butyric acid t-butyl ester
• Synonyms: 4-{2-[4-(2,3-difluoro-benzyloxy)-phenyl]-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl}-butyric acid t-butyl ester
• CAS NO: 1354910-15-8
• Molecular Weight: 484.543
• Mol File: 1354910-15-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-{2-[4-(2,3-difluoro-benzyloxy)-phenyl]-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl}-butyric acid t-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{2-[4-(2,3-difluoro-benzyloxy)-phenyl]-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl}-butyric acid t-butyl ester(1354910-15-8)
• EPA Substance Registry System: 4-{2-[4-(2,3-difluoro-benzyloxy)-phenyl]-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl}-butyric acid t-butyl ester(1354910-15-8)

Safety Data

• Hazardous Substances Data: 1354910-15-8(Hazardous Substances Data)

Upstream product

• 885272-77-5 2-(4-bromo-phenyl)-4,5,6,7-tetrahydro-oxazolo[4,5-c]pyridine 
• 1017781-96-2 2-(4-bromo-phenyl)-5-methyl-4,5,6,7-tetrahydro-oxazolo[4,5-c]pyridine 
• 1354910-38-5 C₁₃H₁₀BrN₂O⁽¹⁺⁾*I^(1-) 
• 934331-03-0 C₁₂H₉BrN₂O₂ 
• 934331-04-1 2-(4-bromophenyl)[1,3]oxazolo[4,5-c]pyridine 
• 6320-39-4 3-aminopyridin-4-ol 
• 1354910-14-7 4-[2-(4-bromo-phenyl)-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl]-butyric acid t-butyl ester 
• 75853-18-8 (2,3-difluoro-phenyl)-methanol 
• 586-75-4 4-chlorobenzoyl chloride 

Downstream Products

• 1354906-02-7 4-{2-[4-(2,3-difluoro-benzyloxy)-phenyl]-6,7-dihydro-4H-oxazolo[4,5-c]pyridine-5-yl}-butyric acid 

Relevant articles and documents

FUSED HETEROCYCLIC DERIVATIVES AS S1P MODULATORS

The present invention relates to a fused heterocyclic derivative of the formula (I) The variables R1-R4, z, A, Q, X and Y are as defined in the claims. The following heterocycles are exemplified substructures of formula (I): The compounds of formula (I) are modulators of the S1P receptor (Sphingosine-1-phosphate receptor), More specifically, they are agonists of S1P5. The compounds have therapeutic use in treatment of cognitive disorders, age-relate cognitive decline and dementia.